BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19758634)

  • 1. Editorial comment.
    Klatte T
    J Urol; 2009 Nov; 182(5):2136. PubMed ID: 19758634
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Wood CG
    J Urol; 2010 Apr; 183(4):1315-6; discussion 1316. PubMed ID: 20171660
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Haas GP
    Urology; 2010 Feb; 75(2):270. PubMed ID: 20152476
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Weight CJ
    Urology; 2009 Nov; 74(5):1068-9. PubMed ID: 19883823
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment on: Prognosis value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Russo P
    Eur Urol; 2009 Feb; 55(2):459. PubMed ID: 18692952
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Klatte T
    J Urol; 2009 Dec; 182(6):2606. PubMed ID: 19836796
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Kirkali Z
    Eur Urol; 2009 Feb; 55(2):460. PubMed ID: 18692949
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment.
    Shichman SJ
    Urology; 2010 Feb; 75(2):281. PubMed ID: 20152480
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment.
    Lane BR; Campbell SC
    Urology; 2010 Feb; 75(2):281. PubMed ID: 20152479
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment.
    Pantuck AJ
    J Urol; 2010 Mar; 183(3):914. PubMed ID: 20083263
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: predicting occult multifocality of renal cell carcinoma.
    Kirkali Z
    Eur Urol; 2010 Jul; 58(1):126. PubMed ID: 20346576
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment.
    Uzzo RG
    J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
    [No Abstract]   [Full Text] [Related]  

  • 13. Is histologic subtype a significant prognostic factor in renal cell carcinoma?
    Ramsey S; Aitchison M
    Nat Clin Pract Urol; 2005 Aug; 2(8):374-5. PubMed ID: 16474733
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal tumours: the new order.
    Delahunt B; Eble JN
    N Z Med J; 1998 Aug; 111(1072):307-9. PubMed ID: 9765626
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in localized renal cell cancer.
    Knight DA; Stadler WM
    BJU Int; 2007 May; 99(5 Pt B):1212-6. PubMed ID: 17441913
    [No Abstract]   [Full Text] [Related]  

  • 18. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
    Billis A
    Int Braz J Urol; 2004; 30(4):347-8. PubMed ID: 15679982
    [No Abstract]   [Full Text] [Related]  

  • 19. Epithelial tumors of the adult kidney: evaluation of the current diagnostic and prognostic criteria.
    Santinelli A; Mazzucchelli R; Colanzi P; Muzzonigro G; Montironi R
    Adv Clin Path; 2000 Oct; 4(4):214-22. PubMed ID: 11436161
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal cell carcinoma and other concurrent renal neoplasms.
    Petrolla AA; MacLennan GT
    J Urol; 2007 Nov; 178(5):2163. PubMed ID: 17870118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.